Oxbow Advisors’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.86M | Buy |
12,506
+602
| +5% | +$234K | 0.53% | 53 |
|
|
2025
Q1 | $5.18M | Buy |
11,904
+331
| +3% | +$144K | 0.55% | 46 |
|
|
2024
Q4 | $4.27M | Buy |
11,573
+1,147
| +11% | +$423K | 0.5% | 51 |
|
|
2024
Q3 | $5.42M | Buy |
10,426
+54
| +0.5% | +$28.1K | 0.54% | 50 |
|
|
2024
Q2 | $5.62M | Sell |
10,372
-166
| -2% | -$90K | 0.66% | 39 |
|
|
2024
Q1 | $5.46M | Buy |
10,538
+63
| +0.6% | +$32.7K | 0.75% | 43 |
|
|
2023
Q4 | $4.94M | Sell |
10,475
-137
| -1% | -$64.6K | 0.75% | 36 |
|
|
2023
Q3 | $4.62M | Buy |
10,612
+9,837
| +1,269% | +$4.28M | 0.73% | 35 |
|
|
2023
Q2 | $344K | Sell |
775
-69
| -8% | -$30.7K | 0.05% | 157 |
|
|
2023
Q1 | $388K | Sell |
844
-109
| -11% | -$50.1K | 0.07% | 137 |
|
|
2022
Q4 | $489K | Sell |
953
-533
| -36% | -$273K | 0.09% | 130 |
|
|
2022
Q3 | $675K | Hold |
1,486
| – | – | 0.11% | 132 |
|
|
2022
Q2 | $717K | Hold |
1,486
| – | – | 0.1% | 131 |
|
|
2022
Q1 | $730K | Buy |
1,486
+43
| +3% | +$21.1K | 0.07% | 144 |
|
|
2021
Q4 | $669K | Sell |
1,443
-220
| -13% | -$102K | 0.06% | 157 |
|
|
2021
Q3 | $620K | Buy |
+1,663
| New | +$620K | 0.06% | 177 |
|
|
2020
Q2 | – | Sell |
-3,463
| Closed | -$786K | – | 277 |
|
|
2020
Q1 | $786K | Sell |
3,463
-11,053
| -76% | -$2.51M | 0.13% | 133 |
|
|
2019
Q4 | $4.38M | Buy |
14,516
+237
| +2% | +$71.6K | 0.51% | 50 |
|
|
2019
Q3 | $3.43M | Buy |
+14,279
| New | +$3.43M | 0.46% | 56 |
|